|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Harpoon Therapeutics, Inc. (HARP) |
|
|
$0.89 0.00 (0.00%) as of 4:30 Fri 9/1
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
32,670,000 |
| Market
Cap: |
29.20(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.615 - $1.06 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Harpoon Therapeutics is a clinical-stage immunotherapy company. Co.'s Tri-specific T cell Activating Construct (TriTACs) product candidates include: HPN328, which is for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217, which is for the treatment of multiple myeloma; and HPN536, which is for the treatment of ovarian and pancreatic cancers and other mesothelin- expressing solid tumors. Co.'s proprietary TriTAC product candidate is HPN601, which targets the epithelial cell adhesion molecule and is being developed for the treatment of multiple solid tumor indications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
21,397,205 |
21,397,205 |
24,484,205 |
24,494,205 |
| Total Buy Value |
$492,135,715 |
$492,135,715 |
$492,135,715 |
$502,135,715 |
| Total People Bought |
1 |
1 |
3 |
3 |
| Total Buy Transactions |
1 |
1 |
4 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wesche Holger |
Chief Scientific Officer |
• – – |
2020-05-08 |
4 |
OE |
$0.60 |
$600 |
D/D |
1,000 |
53,669 |
|
- |
|
| Wesche Holger |
Chief Scientific Officer |
• – – |
2020-05-07 |
4 |
AS |
$14.13 |
$75,576 |
D/D |
(5,350) |
52,669 |
|
29% |
|
| Wesche Holger |
Chief Scientific Officer |
• – – |
2020-05-07 |
4 |
OE |
$0.60 |
$3,210 |
D/D |
5,350 |
58,019 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-05-01 |
4 |
AS |
$12.07 |
$70,301 |
D/D |
(5,826) |
45,754 |
|
21% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-05-01 |
4 |
OE |
$2.12 |
$12,351 |
D/D |
5,826 |
51,580 |
|
- |
|
| Wesche Holger |
Chief Scientific Officer |
• – – |
2020-04-28 |
4 |
AS |
$14.05 |
$17,565 |
D/D |
(1,250) |
52,669 |
|
6% |
|
| Wesche Holger |
Chief Scientific Officer |
• – – |
2020-04-28 |
4 |
OE |
$0.60 |
$750 |
D/D |
1,250 |
53,919 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-17 |
4 |
AS |
$12.08 |
$12,330 |
D/D |
(1,021) |
45,754 |
|
1% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-17 |
4 |
OE |
$2.12 |
$2,165 |
D/D |
1,021 |
46,775 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-16 |
4 |
AS |
$12.00 |
$6,000 |
D/D |
(500) |
45,754 |
|
8% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-16 |
4 |
OE |
$2.12 |
$1,060 |
D/D |
500 |
46,254 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-13 |
4 |
AS |
$12.06 |
$54,959 |
D/D |
(4,556) |
45,754 |
|
2% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-13 |
4 |
OE |
$2.12 |
$9,659 |
D/D |
4,556 |
50,310 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-07 |
4 |
AS |
$12.00 |
$6,840 |
D/D |
(570) |
45,754 |
|
8% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-07 |
4 |
OE |
$2.12 |
$1,208 |
D/D |
570 |
46,324 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-06 |
4 |
AS |
$12.00 |
$8,401 |
D/D |
(700) |
45,754 |
|
2% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-04-06 |
4 |
OE |
$2.12 |
$1,484 |
D/D |
700 |
46,454 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-03-17 |
4 |
AS |
$12.00 |
$18,240 |
D/D |
(1,520) |
45,754 |
|
6% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-03-17 |
4 |
OE |
$2.12 |
$3,222 |
D/D |
1,520 |
47,274 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-03-16 |
4 |
AS |
$12.00 |
$12 |
D/D |
(1) |
45,754 |
|
20% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-03-16 |
4 |
OE |
$2.12 |
$2 |
D/D |
1 |
45,755 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-03-02 |
4 |
AS |
$14.68 |
$85,526 |
D/D |
(5,826) |
45,754 |
|
-0% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-03-02 |
4 |
OE |
$2.12 |
$12,351 |
D/D |
5,826 |
51,580 |
|
- |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-02-18 |
4 |
AS |
$15.00 |
$22,815 |
D/D |
(1,521) |
45,754 |
|
13% |
|
| Sacks Natalie |
Chief Medical Officer |
• – – |
2020-02-18 |
4 |
OE |
$2.12 |
$3,225 |
D/D |
1,521 |
47,275 |
|
- |
|
213 Records found
|
|
Page 6 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
